首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Frontiers in oncology

缩写:FRONT ONCOL

ISSN:2234-943X

e-ISSN:2234-943X

IF/分区:3.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引32231
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Kunzhong Zhou,Yuewen Li,Weifang Wang et al. Kunzhong Zhou et al.
Therapeutic responses to identical chemotherapy regimens often vary significantly among patients with the same type of cancer, underscoring the need for additional biomarkers to identify individuals most likely to benefit from specific trea...
Yan Lin,Shou-Feng Wang,Huan-Wei Liang et al. Yan Lin et al.
Neoadjuvant treatments play a crucial role in improving survival rates for patients with locally advanced resectable esophageal cancer. The CROSS and NEOCRTEC5010 trials have shown that neoadjuvant concurrent chemoradiotherapy significantly...
Juledezi Hailati,Zhiqiang Liu,Lei Zhang et al. Juledezi Hailati et al.
Background: Atrial fibrillation (AF) is a complicated and varied cardiovascular disorder with inadequate understanding of its molecular underpinnings. While Programmed cell death factor 4 (PDCD4) has been associated in se...
Feng Yang,Junxiang Wu,Lucia Clara Orlandini et al. Feng Yang et al.
Radiotherapy plays a crucial role in cancer treatment. Spatially fractionated radiotherapy (SFRT) has garnered significant interest as a therapeutic strategy that delivers alternating regions of high and low radiation doses, thereby optimiz...
Ke Ma,Jie Xu,Congyue Wang et al. Ke Ma et al.
Introduction: The development of high-throughput sequencing technologies and targeted therapeutic strategies has significantly improved the prognosis of lung adenocarcinoma (LUAD) patients with sensitive gene mutations. H...
Chenlei Zhu,Tianyi Xi,Guorong Yang et al. Chenlei Zhu et al.
Background: Breast cancer has severe consequences due to late diagnosis and the lack of effective therapies. Currently, potential biomarkers for breast cancer have not been systematically evaluated. Research has shown tha...
Yue Yang,Shu-Rong Liu,Li Wang et al. Yue Yang et al.
Background: Brentuximab vedotin (BV), an anti-CD30 antibody-drug conjugate, has established efficacy in relapsed/refractory Hodgkin lymphoma (HL), yet its role as frontline therapy for newly diagnosed classical HL require...
Weijun Yang,Wubin Zheng,Jianning Dong et al. Weijun Yang et al.
Background: While prior studies have suggested the potential benefits of preoperative indocyanine green (ICG) fluorescence marking in laparoscopic gastrectomy, few have evaluated its long-term oncologic impact in large re...